Latest Alpha-synuclein Stories
A team of scientists from Japan and the University of California, San Diego School of Medicine have created a new mouse model that confirms that mutations of a protein called beta-synuclein promote neurodegeneration.
A protein linked to Parkinson's disease may cause neurodegeneration by inhibiting autophagyâ€”the process in which cells digest some of their contents.
Yeast could be a powerful ally in the discovery of new therapeutic drugs to treat Parkinson's disease says a scientist presenting his work at the Society for General Microbiology's autumn meeting in Nottingham today.
NEW YORK, July 6 /PRNewswire-USNewswire/ -- The Michael J. Fox Foundation for Parkinson's Research today announced nearly $1.1 million for projects aimed at advancing the development of leading biomarker candidates for Parkinson's disease.
UC San Diego researchers say too much alpha-synuclein shuts down cell communications, helps cause dementia.
NEW YORK, April 23 /PRNewswire-USNewswire/ -- The Michael J. Fox Foundation for Parkinson's Research today announced more than $3 million in previously unannounced awards ending the first quarter of 2010.
NEW YORK, March 2 /PRNewswire-USNewswire/ -- The Michael J. Fox Foundation for Parkinson's Research announced up to $5.75 million in total funding available under its three 2010 Critical Challenges.
NEW YORK, Feb. 9 /PRNewswire-USNewswire/ -- As part of its mission to do whatever it takes to speed development of life-transforming treatments and a cure for Parkinson's disease, The Michael J.
NEW YORK, Jan. 19 /PRNewswire-USNewswire/ -- As part of its mission to speed development of transformative treatments for Parkinson's disease, The Michael J.
FINDINGS: Several structurally similar small molecules appear capable of protecting cells from alpha-synuclein toxicity, a hallmark of Parkinson's disease.
- A volcanic mudflow.